Vapotherm is a worldwide, commercial company that develops, manufactures and sells Precision Flow, a high-velocity oxygen therapy for patients in respiratory distress. By conditioning the oxygen to make it tolerable for patients of all ages, Precision Flow, allows patients to comfortably eat, speak and sleep while receiving a high level of respiratory support. Such support has been shown to help patients avoid expensive and invasive care (such as intubation) and reduce their length of stay within a hospital. The essence of better care at lower cost.

Vapotherm is based in Exeter, New Hampshire.

Vapotherm is now publicly listed on the NYSE under the ticker symbol VAPO.